Boothbay Fund Management’s Shuttle Pharmaceuticals SHPH Stock Holding History

Boothbay Fund Management’s Portfolio SHPH Stock Details SHPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.8K	Hold	2,036	–	–	﹤0.01%	1986
2025 Q4	$36.6K	Buy	+2,036	New	+$52.1K	﹤0.01%	1844

Other funds holding SHPH

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

KFA

Kelleher Financial Advisors New York $395M AUM 12.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's SHPH Position: Q1 2026 in Review

Boothbay Fund Management held its Shuttle Pharmaceuticals (SHPH) position steady in Q1 2026 at 2,036 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Boothbay Fund Management first reported a position in SHPH in Q4 2025 and has held it in 2 quarters since. The position peaked at $36.6K in Q4 2025. 8 funds tracked by Wall St. Rank hold SHPH as of Q1 2026.

Boothbay Fund Management held 2,036 shares of Shuttle Pharmaceuticals worth $13.8K as of Q1 2026.
Boothbay Fund Management left its Shuttle Pharmaceuticals share count unchanged in Q1 2026.
Shuttle Pharmaceuticals made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1986 holding.
Boothbay Fund Management first reported a position in Shuttle Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
Boothbay Fund Management's Shuttle Pharmaceuticals position peaked at $36.6K in Q4 2025.
8 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.